1940 related articles for article (PubMed ID: 21883834)
1. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
[TBL] [Abstract][Full Text] [Related]
2. Core lower urinary tract symptom score (CLSS) for the assessment of female lower urinary tract symptoms: a comparative study.
Fujimura T; Kume H; Tsurumaki Y; Yoshimura Y; Hosoda C; Suzuki M; Fukuhara H; Enomoto Y; Nishimatsu H; Homma Y
Int J Urol; 2011 Nov; 18(11):778-84. PubMed ID: 21951201
[TBL] [Abstract][Full Text] [Related]
3. Association between lower urinary tract symptoms and sexual dysfunction assessed using the core lower urinary tract symptom score and International Index of Erectile Function-5 questionnaires.
Nakamura M; Fujimura T; Nagata M; Hosoda C; Suzuki M; Fukuhara H; Enomoto Y; Nishimatsu H; Kume H; Igawa Y; Homma Y
Aging Male; 2012 Jun; 15(2):111-4. PubMed ID: 22283118
[TBL] [Abstract][Full Text] [Related]
4. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.
Fukuta F; Masumori N; Mori M; Tsukamoto T
BJU Int; 2012 Oct; 110(7):1023-9. PubMed ID: 22233355
[TBL] [Abstract][Full Text] [Related]
5. Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS).
Coyne KS; Barsdorf AI; Thompson C; Ireland A; Milsom I; Chapple C; Kopp ZS; Bavendam T
Neurourol Urodyn; 2012 Apr; 31(4):448-54. PubMed ID: 22396308
[TBL] [Abstract][Full Text] [Related]
6. Core Lower Urinary Tract Symptom score (CLSS) questionnaire: a reliable tool in the overall assessment of lower urinary tract symptoms.
Homma Y; Yoshida M; Yamanishi T; Gotoh M
Int J Urol; 2008 Sep; 15(9):816-20. PubMed ID: 18657204
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of self-estimation of disuric disorders gauged IPSS scale and qualities of lives QoL with self-estimation of sexual life gauged by IIEF-5 scale].
Lipczyński W; Dobrowolska-Glazar B; Dobrowolski ZF
Przegl Lek; 2012; 69(6):247-52. PubMed ID: 23094437
[TBL] [Abstract][Full Text] [Related]
8. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
[TBL] [Abstract][Full Text] [Related]
10. New classification for men with lower urinary tract symptoms: cluster analysis using the International Prostate Symptom Score.
Aikawa K; Yamaguchi O; Oguro T; Ishibashi K; Yanagida T; Nomiya M; Haga N; Yoshiyasu T; Kobayashi T
BJU Int; 2012 Aug; 110(3):408-12. PubMed ID: 22093177
[TBL] [Abstract][Full Text] [Related]
11. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
[TBL] [Abstract][Full Text] [Related]
12. Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia.
Takao T; Tsujimura A; Kiuchi H; Takezawa K; Okuda H; Yamamoto K; Fukuhara S; Miyagawa Y; Nonomura N
Urology; 2013 Jul; 82(1):189-93. PubMed ID: 23642937
[TBL] [Abstract][Full Text] [Related]
13. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
14. Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient.
Kingery L; Martin ML; Naegeli AN; Khan S; Viktrup L
Int J Clin Pract; 2012 Sep; 66(9):883-90. PubMed ID: 22897465
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the clinical value of a simple flowmeter in the management of male lower urinary tract symptoms.
Chan CK; Yip SK; Wu IP; Li ML; Chan NH
BJU Int; 2012 Jun; 109(11):1690-6. PubMed ID: 21933332
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of lower urinary tract symptoms in men and its influence on their quality of life: Boxmeer Study].
Sonke GS; Kolman D; de la Rosette JJ; Donkers LH; Boyle P; Kiemeney LA
Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2558-63. PubMed ID: 11191793
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms.
Liao CH; Chung SD; Kuo HC
Int J Clin Pract; 2011 May; 65(5):552-8. PubMed ID: 21489080
[TBL] [Abstract][Full Text] [Related]
18. Association between the self-perception period of lower urinary tract symptoms and the International Prostate Symptom Score.
Shim SR; Kim JH; Kim KH; Yoon SJ; Lee WJ; Kim HJ; Bae JH
Urol Int; 2012; 88(4):431-7. PubMed ID: 22414894
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of lower urinary tract symptoms using a visual analog scale in men undergoing permanent brachytherapy.
Okihara K; Ukimura O; Ushijima S; Kamoi K; Iwata T; Kobayashi K; Naitoh Y; Yamazaki H; Kawauchi A; Miki T
Brachytherapy; 2012; 11(4):265-70. PubMed ID: 21996538
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of lower urinary tract symptoms and bother in both sexes.
Terai A; Matsui Y; Ichioka K; Ohara H; Terada N; Yoshimura K
Urology; 2004 Mar; 63(3):487-91. PubMed ID: 15028443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
